HLN — Haleon plc

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Market Cap

$43.45B

P/E Ratio

31.32

Beta

0.33

52-Week Range

8.71-11.42

Dividend Yield

$0.30

CEO

Brian James McNamara

Employees

24,561

IPO Date

Jul 25, 2022

Exchange

NYSE